Cargando…
Development of the India COVID-19 vaccine tracker
COVID-19 was declared a pandemic by the World Health Organization (WHO) on March 11, 2020. Since then, efforts were initiated to develop safe and effective vaccines. Till date, 11 vaccines have been included in the WHO’s emergency use list. The emergence and spread of variant strains of SARS-CoV-2 h...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807209/ https://www.ncbi.nlm.nih.gov/pubmed/35859397 http://dx.doi.org/10.4103/ijmr.ijmr_3500_21 |
_version_ | 1784862672692445184 |
---|---|
author | Singh, Harpreet Lohia, Rohan George, Leyanna Susan Gupta, Nivedita Thangaraj, Jeromie Winsley Rana, Salaj Rana, Shweta Kaur, Jasmine Shivam, Shashwat Arora, Narendra Kumar Muliyil, Jai Prakash Murhekar, Manoj V. Lodha, Rakesh Pandey, R.M. Rao, Vishnu Vardhan Dhandore, Suhas Malik, Akash Kumar, Vijay Tripathi, Ankit Panda, Samiran Bhargava, Balram |
author_facet | Singh, Harpreet Lohia, Rohan George, Leyanna Susan Gupta, Nivedita Thangaraj, Jeromie Winsley Rana, Salaj Rana, Shweta Kaur, Jasmine Shivam, Shashwat Arora, Narendra Kumar Muliyil, Jai Prakash Murhekar, Manoj V. Lodha, Rakesh Pandey, R.M. Rao, Vishnu Vardhan Dhandore, Suhas Malik, Akash Kumar, Vijay Tripathi, Ankit Panda, Samiran Bhargava, Balram |
author_sort | Singh, Harpreet |
collection | PubMed |
description | COVID-19 was declared a pandemic by the World Health Organization (WHO) on March 11, 2020. Since then, efforts were initiated to develop safe and effective vaccines. Till date, 11 vaccines have been included in the WHO’s emergency use list. The emergence and spread of variant strains of SARS-CoV-2 has altered the disease transmission dynamics, thus creating a need for continuously monitoring the real-world effectiveness of various vaccines and assessing their overall impact on disease control. To achieve this goal, the Indian Council of Medical Research (ICMR) along with the Ministry of Health and Family Welfare, Government of India, took the lead to develop the India COVID-19 Vaccination Tracker by synergizing three different public health databases: National COVID-19 testing database, CoWIN vaccination database and the COVID-19 India portal. A Vaccine Data Analytics Committee (VDAC) was constituted to advise on various modalities of the proposed tracker. The VDAC reviewed the data related to COVID-19 testing, vaccination and patient outcomes available in the three databases and selected relevant data points for inclusion in the tracker, following which databases were integrated, using common identifiers, wherever feasible. Multiple data filters were applied to retrieve information of all individuals ≥18 yr who died after the acquisition of COVID-19 infection with or without vaccination, irrespective of the time between vaccination and test positivity. Vaccine effectiveness (VE) against the reduction of mortality and hospitalizations was initially assessed. As compared to the hospitalization data, mortality reporting was found to be much better in terms of correctness and completeness. Therefore, hospitalization data were not considered for analysis and presentation in the vaccine tracker. The vaccine tracker thus depicts VE against mortality, calculated by a cohort approach using person-time analysis. Incidence of COVID-19 deaths among one- and two-dose vaccine recipients was compared with that among unvaccinated groups, to estimate the rate ratios (RRs). VE was estimated as 96.6 and 97.5 per cent, with one and two doses of the vaccines, respectively, during the period of reporting. The India COVID-19 Vaccination Tracker was officially launched on September 9, 2021. The high VE against mortality, as demonstrated by the tracker, has helped aid in allaying vaccine hesitancy, augmenting and maintaining the momentum of India’s COVID-19 vaccination drive. |
format | Online Article Text |
id | pubmed-9807209 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-98072092023-01-03 Development of the India COVID-19 vaccine tracker Singh, Harpreet Lohia, Rohan George, Leyanna Susan Gupta, Nivedita Thangaraj, Jeromie Winsley Rana, Salaj Rana, Shweta Kaur, Jasmine Shivam, Shashwat Arora, Narendra Kumar Muliyil, Jai Prakash Murhekar, Manoj V. Lodha, Rakesh Pandey, R.M. Rao, Vishnu Vardhan Dhandore, Suhas Malik, Akash Kumar, Vijay Tripathi, Ankit Panda, Samiran Bhargava, Balram Indian J Med Res Special Report COVID-19 was declared a pandemic by the World Health Organization (WHO) on March 11, 2020. Since then, efforts were initiated to develop safe and effective vaccines. Till date, 11 vaccines have been included in the WHO’s emergency use list. The emergence and spread of variant strains of SARS-CoV-2 has altered the disease transmission dynamics, thus creating a need for continuously monitoring the real-world effectiveness of various vaccines and assessing their overall impact on disease control. To achieve this goal, the Indian Council of Medical Research (ICMR) along with the Ministry of Health and Family Welfare, Government of India, took the lead to develop the India COVID-19 Vaccination Tracker by synergizing three different public health databases: National COVID-19 testing database, CoWIN vaccination database and the COVID-19 India portal. A Vaccine Data Analytics Committee (VDAC) was constituted to advise on various modalities of the proposed tracker. The VDAC reviewed the data related to COVID-19 testing, vaccination and patient outcomes available in the three databases and selected relevant data points for inclusion in the tracker, following which databases were integrated, using common identifiers, wherever feasible. Multiple data filters were applied to retrieve information of all individuals ≥18 yr who died after the acquisition of COVID-19 infection with or without vaccination, irrespective of the time between vaccination and test positivity. Vaccine effectiveness (VE) against the reduction of mortality and hospitalizations was initially assessed. As compared to the hospitalization data, mortality reporting was found to be much better in terms of correctness and completeness. Therefore, hospitalization data were not considered for analysis and presentation in the vaccine tracker. The vaccine tracker thus depicts VE against mortality, calculated by a cohort approach using person-time analysis. Incidence of COVID-19 deaths among one- and two-dose vaccine recipients was compared with that among unvaccinated groups, to estimate the rate ratios (RRs). VE was estimated as 96.6 and 97.5 per cent, with one and two doses of the vaccines, respectively, during the period of reporting. The India COVID-19 Vaccination Tracker was officially launched on September 9, 2021. The high VE against mortality, as demonstrated by the tracker, has helped aid in allaying vaccine hesitancy, augmenting and maintaining the momentum of India’s COVID-19 vaccination drive. Wolters Kluwer - Medknow 2022 2022-10-28 /pmc/articles/PMC9807209/ /pubmed/35859397 http://dx.doi.org/10.4103/ijmr.ijmr_3500_21 Text en Copyright: © 2022 Indian Journal of Medical Research https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Special Report Singh, Harpreet Lohia, Rohan George, Leyanna Susan Gupta, Nivedita Thangaraj, Jeromie Winsley Rana, Salaj Rana, Shweta Kaur, Jasmine Shivam, Shashwat Arora, Narendra Kumar Muliyil, Jai Prakash Murhekar, Manoj V. Lodha, Rakesh Pandey, R.M. Rao, Vishnu Vardhan Dhandore, Suhas Malik, Akash Kumar, Vijay Tripathi, Ankit Panda, Samiran Bhargava, Balram Development of the India COVID-19 vaccine tracker |
title | Development of the India COVID-19 vaccine tracker |
title_full | Development of the India COVID-19 vaccine tracker |
title_fullStr | Development of the India COVID-19 vaccine tracker |
title_full_unstemmed | Development of the India COVID-19 vaccine tracker |
title_short | Development of the India COVID-19 vaccine tracker |
title_sort | development of the india covid-19 vaccine tracker |
topic | Special Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807209/ https://www.ncbi.nlm.nih.gov/pubmed/35859397 http://dx.doi.org/10.4103/ijmr.ijmr_3500_21 |
work_keys_str_mv | AT singhharpreet developmentoftheindiacovid19vaccinetracker AT lohiarohan developmentoftheindiacovid19vaccinetracker AT georgeleyannasusan developmentoftheindiacovid19vaccinetracker AT guptanivedita developmentoftheindiacovid19vaccinetracker AT thangarajjeromiewinsley developmentoftheindiacovid19vaccinetracker AT ranasalaj developmentoftheindiacovid19vaccinetracker AT ranashweta developmentoftheindiacovid19vaccinetracker AT kaurjasmine developmentoftheindiacovid19vaccinetracker AT shivamshashwat developmentoftheindiacovid19vaccinetracker AT aroranarendrakumar developmentoftheindiacovid19vaccinetracker AT muliyiljaiprakash developmentoftheindiacovid19vaccinetracker AT murhekarmanojv developmentoftheindiacovid19vaccinetracker AT lodharakesh developmentoftheindiacovid19vaccinetracker AT pandeyrm developmentoftheindiacovid19vaccinetracker AT raovishnuvardhan developmentoftheindiacovid19vaccinetracker AT dhandoresuhas developmentoftheindiacovid19vaccinetracker AT malikakash developmentoftheindiacovid19vaccinetracker AT kumarvijay developmentoftheindiacovid19vaccinetracker AT tripathiankit developmentoftheindiacovid19vaccinetracker AT pandasamiran developmentoftheindiacovid19vaccinetracker AT bhargavabalram developmentoftheindiacovid19vaccinetracker |